Comparison of proliferation indices in primary adult-type granulosa cell tumors of the ovary and their corresponding metastases: An analysis of 14 cases

International Journal of Gynecological Pathology

Volumn 28, Issue 5, 2009, Pages 423-431

  Stewart, Colin J R ^a,b   Brennan, Barbara A ^a   Crook, Maxine L ^a   Doherty, Dorota A ^c   Hammond, Ian G ^a   Leuverink, Esther ^a   Ruba, Sukeerat ^a  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Comparison; Granulosa cell tumor; Metastasis; Ovary; Proliferation

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SURGERY; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; FEMALE; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABELING INDEX; METASTASIS; MORPHOLOGY; OVARY; OVARY TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; TUMOR RECURRENCE;

ADULT; FEMALE; GRANULOSA CELL TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; MITOTIC INDEX; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 69749121411     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e31819d8153     Document Type: Article

References (45)

1. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol 2003;21:1180-1189
2. Stuart GCE, Dawson LM. Update on granulosa cell tumours of the ovary. Curr Opin Obstet Gynecol 2003;15:33-37 (Pubitemid 36143490)
3. Pectasides D, Pectasides E, Psyrri A. Granulosa cell tumor of the ovary. Cancer Treat Rev 2008;34:1-12.
4. Fox H. Pathological prognostic factors in early stage adult-type granulosa cell tumors of the ovary. Int J Gynecol Cancer 2003;13:1-4. (Pubitemid 36292717)
5. Miller K, McCluggage WG. Prognostic factors in ovarian adult granulosa cell tumour. J Clin Pathol 2008;61:881-884
6. McNeilage J, Alexiadis M, Susil BJ, et al. Molecular characterization of sarcomatous change in a granulosa cell tumor. Int J Gynecol Cancer 2007;17:398-406. (Pubitemid 46426779)
7. Susil BJ, Sumithran E. Sarcomatous change in granulosa cell tumor. Hum Pathol 1987;18:397-399 (Pubitemid 17071040)
8. Ala-Fossi S-L, Aine R, Punnonen R, et al. Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumors? Eur J Gynaecol Oncol 2000;21:187-189
9. Gebhart JB, Roche PC, Keeney GL, et al. Assessment of inhibin and p53 in granulosa cell tumors of the ovary. Gynecol Oncol 2000;77:232-236
10. Wabersich J, Fracas M, Mazzer S, et al. The value of the prognostic factors in ovarian granulosa cell tumors. Eur J Gynaecol Oncol 1998;19:69-72. (Pubitemid 28040700)
11. Costa MJ, Walls J, Ames P, et al. Transformation in recurrent ovarian granulosa cell tumors: Ki-67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behaviour. Hum Pathol 1996;27:274-281 (Pubitemid 26078908)
12. Furger C, Fiddes RJ, Quinn DI, et al. Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of Heregulin-beta/PE40. Cancer Res 1998;58:1773-1778 (Pubitemid 28217444)
13. Leibl S, Bodo K, Fogg-Kammerer M, et al. Ovarian granulosa cell tumors frequently express EGFR (Her-1), Her-3, and Her-4: an immunohistochemical study. Gynecol Oncol 2006;101:18-23. (Pubitemid 43303554)
14. Chu S, Alexiadis M, Fuller PJ. Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors. Gynecol Oncol 2008;108:182-190
15. Going JJ. Counting cells made easier. Histopathology 2006;49:309-311
16. Leuverink EM, Brennan BA, Crook M, et al. Prognostic value of mitotic counts and Ki-67 immunoreactivity in adult-type granulosa cell tumour of the ovary. J Clin Pathol 2008;61:914-919
17. Thunissen FBJM, Ambergen AW, Koss M, et al. Mitotic counting in surgical pathology: sampling bias, heterogeneity and statistical uncertainty. Histopathology 2001;39:1-8. (Pubitemid 32848268)
18. Therneau TM, Grambsch PM. Multiple events for subject. Modelling Survival Data: Extending the Cox Model. New York: Springer Verlag; 2000:169-229.
19. Ifaturoti O, Crocker SG. Ovarian granulosa cell tumour recurring 36 years after primary treatment. J Obstet Gynaecol 2004;24:331-332 (Pubitemid 38491228)
20. Chew DKW, Schutzer RW, Domer GS, et al. Splenic rupture from metastatic granulosa cell tumor 29 years after curative resection: case report and review of the literature. Am Surg 2003;69:106-108
21. Crew KD, Cohen MH, Smith DH, et al. Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol 2005;96:235-240 (Pubitemid 39614236)
22. Hines JF, Khalifa MA, Moore JL, et al. Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol 1996;60:484-488
23. Stenwig JT, Hazekamp JT, Beecham JB. Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 1979;7:136-153
24. Bjorkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol 1981;11:261-274
25. Malmstrom H, Hogberg T, Risberg B, et al. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol 1994;52:50-55 (Pubitemid 24066852)
26. King LA, Okagaki T, Gallup DG, et al. Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. Gynecol Oncol 1996;61:227-232 (Pubitemid 26145729)
27. Miller BE, Barron BA, Wan JY, et al. Prognostic factors in adult granulosa cell tumor of the ovary. Cancer 1997;79:1951-1955 (Pubitemid 27200379)
28. Juric G, Zarkovic N, Nola M, et al. The value of cell proliferation and angiogenesis in the prognostic assessment of ovarian granulosa cell tumors. Tumori 2001;87:47-53. (Pubitemid 32273852)
29. Lauszus FF, Petersen AC, Greisen J, et al. Granulosa cell tumor of the ovary: a population-based study of 37 women with stage 1 disease. Gynecol Oncol 2001;81:456-460 (Pubitemid 32494662)
30. Miller BE, Barron BA, Dockter ME, et al. Parameters of differentiation and proliferation in adult granulosa cell tumors of the ovary. Cancer Detect Prev 2001;25:48-54.
31. Fujimoto T, Sakuragi N, Okuyama K, et al. Histopathological prognostic factors of adult granulosa cell tumors of the ovary. Acta Obstet Gynecol Scand 2001;80:1069-1074 (Pubitemid 33052226)
32. Kusamura S, Derchain S, Alvarenga M, et al. Expression of p53, c-erbB-2, Ki-67, and CD34 in granulosa cell tumor of the ovary. Int J Gynecol Cancer 2003;13:450-457 (Pubitemid 38228341)
33. Sehouli J, Drescher FS, Mustea A, et al. Granulosa cell tumor of the ovary: 10 years follow up data of 65 patients. Anticancer Res 2004;24:1223-1230 (Pubitemid 38624966)
34. Kim YM, Jung MH, Kim KR, et al. Adult granulosa cell tumor of the ovary: 35 cases in a single Korean institute. Acta Obstet Gynaecol 2006;85:112-115
35. Lin Y-S, Eng HL, Jan YJ, et al. Molecular cytogenetics of ovarian granulosa cell tumors by comparative genomic hybridization. Gynecol Oncol 2005;97:68-73. (Pubitemid 40403676)
36. Auranen A, Sundstrom J, Ijas J, et al. Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature. Int J Gynecol Cancer 2007;17:1011-1018 (Pubitemid 47414826)
37. Villella J, Hermann FR, Kaul S, et al. Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary. Int J Gynecol Path 2007;26:154-159 (Pubitemid 46573211)
38. Cabibi D, Calascibetta A, Martorana A, et al. Different expression of thymidylate synthetase in primary tumor and metastatic nodes in breast cancer patients. Anticancer Res 2007;27:2227-2230 (Pubitemid 47228057)
39. Graflund M, Sorbe B, Karlsson M. MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome. Int J Gynecol Oncol 2002;20:1041-1047
40. Mayer A, Takimoto M, Fritz E, et al. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993;71:2454-2460 (Pubitemid 23100476)
41. Seong J, Chung EJ, Kim H, et al. Assessment of biomarkers in paired primary and recurrent colorectal adenocarcinomas. Int J Radiation Oncology Biol Phys 1999;45:1167-1173
42. McKay JA, Douglas JJ, Ross VG, et al. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. Clin Cancer Res 2000;6:1113-1118
43. Cross SS, Sanderson T, Vergani P, et al. Tumour heterogeneity and the assessment of expression of proteins for targeted biological therapies. Diagn Histopathol 2007;14:55-59
44. Colombo N, Parma G, Zanagnolo V, et al. Management of ovarian stromal cell tumors. J Clin Oncol 2007;25:2944-2951 (Pubitemid 47123159)
45. Al-Badawi IA, Brasher PM, Ghatage P, et al. Postoperative chemotherapy in advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 2002;12:119-123 (Pubitemid 34202960)